Alitretinoin
Pronunciation
(a li TRET i noyn)
U.S. Brand Names
Panretin®
Generic Available
No
Canadian Brand Names
Panretin®
Use
Orphan drug:
Topical treatment of cutaneous lesions in AIDS-related Kaposi's sarcoma
Use - Unlabeled/Investigational
Cutaneous T-cell lymphomas
Pregnancy Risk Factor
D
Pregnancy Implications
Potentially teratogenic and/or embryotoxic; limb, craniofacial, or skeletal defects have been observed in animal models. If used during pregnancy or if the patient becomes pregnant while using alitretinoin, the woman should be advised of potential harm to the fetus. Women of childbearing potential should avoid becoming pregnant.
Lactation
Excretion in breast milk unknown/not recommended
Contraindications
Hypersensitivity to alitretinoin, other retinoids, or any component of the formulation; pregnancy
Warnings/Precautions
May cause fetal harm if absorbed by a woman who is pregnant. May be photosensitizing (based on experience with other retinoids); minimize sun or other UV exposure of treated areas. Do not use concurrently with topical products containing DEET (increased toxicity may result). Safety in pediatric patients or geriatric patients has not been established.
Adverse Reactions
>10%:
Central nervous system: Pain (0% to 34%)
Dermatologic: Rash (25% to 77%), pruritus (8% to 11%)
Neuromuscular & skeletal: Paresthesia (3% to 22%)
5% to 10%:
Cardiovascular: Edema (3% to 8%)
Dermatologic: Exfoliative dermatitis (3% to 9%), skin disorder (0% to 8%)
Overdosage/Toxicology
There has been no experience with human overdosage of alitretinoin, and overdose is unlikely following topical application. Treatment is symptomatic and supportive.
Drug Interactions
Increased toxicity of DEET may occur if products containing this compound are used concurrently with alitretinoin. Due to limited absorption after topical application, interaction with systemic medications is unlikely.
Stability
Store at room temperature
Mechanism of Action
Binds to retinoid receptors to inhibit growth of Kaposi's sarcoma
Pharmacodynamics/Kinetics
Absorption: Not extensive
Dosage
Topical: Apply gel twice daily to cutaneous Kaposi's sarcoma or T-cell lymphoma (unlabeled use) lesions
Administration
Do not use occlusive dressings.
Patient Education
For external use only. Use exactly as directed; do not overuse. Avoid use of any product such as insect repellents which contain DEET (check with your pharmacist). Wear protective clothing and/or avoid exposure to direct sun or sunlamps. Wash hands thoroughly before applying. Avoid applying skin products that contain alcohol or harsh chemicals during treatment. Do not apply occlusive dressings. Stop treatment and inform prescriber if rash, skin irritation, redness, scaling, or excessive dryness appears.
Pregnancy/breast-feeding precautions:
Do not get pregnant while taking this medication. Consult prescriber for appropriate contraceptive measures. Breast-feeding is not recommended.
Dental Health: Effects on Dental Treatment
No significant effects or complications reported
Dental Health: Vasoconstrictor/Local Anesthetic Precautions
No information available to require special precautions
Mental Health: Effects on Mental Status
Pain is common
Mental Health: Effects on Psychiatric Treatment
May be photosensitizing; caution with psychotropics
Oncology: Emetic Potential
Very low (<10%)
Dosage Forms
Gel: 0.1% (60 g tube)
International Brand Names
Panretin™ (CA); Panretin® (FR)
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's
accreditation program
is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s
editorial process
. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
|
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.